Stocks · Healthcare · Biotechnology
BioAge Labs Inc. BIOA
$6.61 -2.94% Close, Oct 2, 2026 · NASDAQ · Market cap $248.9M
Expensive vs sectorHigh risk
Next earnings report: Nov 5, 2026
Scroll or pinch to zoom, drag to move. Daily prices adjusted for splits. Markers: E = earnings (green beat, red miss), S = split, D = dividend.
Three things to know
- Revenue over the last four quarters was $10.4M, up 168.1% from a year earlier, slowing from 611.0% a quarter earlier.
- Operating margin widened to -1026.3% from -2364.2% a year earlier.
- The diluted share count rose 25.1% in a year.
PromtFinance scores
Each score is a percentile within the Healthcare sector (0–100). Under each score: how the stock ranks in its sector on every component. As of Oct 5, 2026.
How fast revenue, earnings and cash flow are growing.
- Revenue growth (TTM, YoY)Top 8%
- Revenue growth accelerationBottom 1%
Returns on capital, margins, earnings quality and balance-sheet strength.
- Return on invested capitalBottom 43%
- Gross marginTop 7%
- Operating marginBottom 11%
- Accruals (lower is better)Bottom 22%
- Interest coverBottom 9%
How cheap the shares are relative to earnings, cash flow and their own history.
- Earnings yieldBottom 20%
- Free-cash-flow yieldBottom 14%
- EBITDA / enterprise valueBottom 12%
- Sales / enterprise valueBottom 23%
Strength and persistence of the price trend, including versus the S&P 500.
- 12-month return excluding last monthTop 27%
- 6-month returnBottom 2%
- 1-year return vs S&P 500Bottom 49%
- Distance from 52-week highBottom 6%
- Trend checklist (0–4)Bottom 14%
Earnings surprises and analyst sentiment (estimate-revision history is being collected).
- Average EPS surprise, last 4 quartersTop 33%
- Consecutive EPS beatsTop 19%
- Share of analysts rating BuyTop 38%
- Upside to consensus price targetTop 9%
Low volatility, shallow drawdowns, low market sensitivity and modest leverage.
- Volatility, 60 days (lower is better)Bottom 1%
- Maximum drawdown, 3 yearsBottom 19%
- Beta vs S&P 500 (lower is better)Bottom 23%
What changed
Latest four quarters versus the same period a year earlier (growth: versus one quarter earlier).
| Measure | Before | Now | |
|---|---|---|---|
| Revenue growth (YoY) | 611.0% | 168.1% | ↓ |
| Gross margin | 100.0% | 99.4% | ↓ |
| Operating margin | -2364.2% | -1026.3% | ↑ |
| FCF margin | -1509.6% | -850.7% | ↑ |
Fundamental momentum
| Measure | Now (TTM) | Year / quarter before | Sector rank | |
|---|---|---|---|---|
| Revenue growth (TTM, YoY) | 168.1% | 611.0% | ↓ | Top 8% |
| Gross margin | 99.4% | 100.0% | ↓ | Top 7% |
| Operating margin | -1026.3% | -2364.2% | ↑ | Bottom 11% |
| Net margin | -912.3% | -2045.7% | ↑ | — |
| Free-cash-flow margin | -850.7% | -1509.6% | ↑ | — |
| Return on invested capital | -28.1% | — | Bottom 43% |
Quality of earnings and balance sheet
- Accruals (net income − OCF) / assetsLower is better; high accruals can signal weaker earnings quality.
- -1.7%
- Stock-based compensation / revenueA cost to shareholders through dilution.
- 135.6%
- Receivables growth vs revenue growthReceivables growing much faster than sales can be a warning.
- -164.4 pp
- Net debt / EBITDABelow 1× is conservative; above 3× is high leverage.
- Net cash
- Interest cover (operating income / interest)How many times operating profit covers interest.
- -378.2×
Shareholder returns
- Dividend yield (dividends paid, TTM)
- 0.00%
- Net buyback yield (TTM)
- -64.78%
- Shareholder yield
- -64.78%
- Share count change, 1 year
- +25.1%
- Share count change, 3-year CAGR
- +9.5%
Shareholder yield = dividends + net buybacks over the last four quarters, divided by market cap.
Based on the four quarters through Jun 30, 2026 (filed Aug 5, 2026).
Earnings and expectations
Earnings momentum
- Consecutive EPS beats
- 4
- Beats in the last 8 reports
- 5 of 8
- Average EPS surprise, last 4
- +13.2%
- Average 2-day reaction, last 8
- -3.6%
- Positive 20 days after report
- 3 of 8
Analysts
- Consensus price target
- $28.67
- Target vs current price
- +333.7%
- Analysts with a rating
- 6
- Share rating Buy or Strong Buy
- 83%
- Consensus rating
- Buy
How the stock reacted to recent reports
| Report date | EPS surprise | 2 days | 5 days | 20 days | 60 days |
|---|---|---|---|---|---|
| Aug 6, 2026 | +4.5% | +2.6% | -4.6% | -11.4% | — |
| May 8, 2026 | +18.7% | +1.0% | +5.1% | -11.9% | -37.1% |
| Mar 24, 2026 | +13.3% | -13.5% | -15.0% | +5.3% | +7.3% |
| Nov 6, 2025 | +16.4% | -0.4% | +6.8% | +40.0% | +165.5% |
| Aug 6, 2025 | -7.1% | -2.5% | +0.9% | +6.8% | +73.0% |
| May 6, 2025 | +30.8% | -4.8% | -1.9% | -3.9% | +6.0% |
| Mar 20, 2025 | -72.4% | -1.4% | -10.1% | -15.5% | +1.8% |
| Nov 7, 2024 | -830.6% | -10.1% | -12.1% | -19.9% | -79.9% |
Returns from the close before each report. Past reactions do not determine future ones.
Earnings history
| Report date | EPS | Estimate | Surprise | Revenue |
|---|---|---|---|---|
| Aug 6, 2026 | -$0.58 | -$0.61 | +4.5% | $2.5M |
| May 8, 2026 | -$0.52 | -$0.64 | +18.7% | $2.8M |
| Mar 24, 2026 | -$0.72 | -$0.83 | +13.3% | $3.1M |
| Nov 6, 2025 | -$0.56 | -$0.67 | +16.4% | $2.1M |
| Aug 6, 2025 | -$0.60 | -$0.56 | -7.1% | $2.4M |
| May 6, 2025 | -$0.36 | -$0.52 | +30.8% | $1.5M |
| Mar 20, 2025 | -$1.00 | -$0.58 | -72.4% | — |
| Nov 7, 2024 | -$6.70 | -$0.72 | -830.6% | — |
Valuation in context
| Multiple | Now | 5-year median | 5-year percentile | Sector rank (cheapness) |
|---|---|---|---|---|
| EV / Sales | 17.16× | — | — | Bottom 23% |
| Free-cash-flow yield | -35.40% | — | — | Bottom 14% |
| Earnings yield | -36.01% | — | — | Bottom 20% |
Technical state
Trend checklist
- ✗ Price above 20-day average
- ✗ Price above 50-day average
- ✗ Price above 200-day average
- ✗ 50-day average above 200-day
- ✓ MACD histogram positive
Trend quality
- Days above the 50-day average
- 0
- Days above the 200-day average
- 0
- 50-day average slope (20 days)
- -36.9%
- 200-day average slope (20 days)
- -1.3%
- Distance from 50-day average
- -37.4%
- Distance from 200-day average
- -60.4%
- RSI (14)
- 25.2
- Relative volume
- 1.26×
Risk and drawdowns
- Volatility, 60 days (annualized)
- 218.9%
- Volatility vs own 5-year history
- 78th percentile · Normal for this stock
- Beta vs S&P 500 (2 years, weekly)
- 1.73
- Correlation with S&P 500
- 0.24
- Current drawdown from 1-year high
- -73.7%
- Maximum drawdown, 3 years
- -88.2%
Largest declines in the past six years
| From peak | To low | Decline | Length | Recovery |
|---|---|---|---|---|
| Oct 21, 2024 | Apr 8, 2025 | -88.2% | 115 days | Not yet recovered |
| Oct 8, 2024 | Oct 9, 2024 | -10.1% | 1 days | 3 days (Oct 14, 2024) |
Declines of 10% or more from a closing high, measured on daily closes.
Financial statements
- Market cap
- $248.9M
- EPS, diluted (TTM)
- -$2.38
- Revenue (TTM)
- $10.4M
- 52-week range
- $5.04 – $25.96
| FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $9.0M |
| Gross profit | $0 | $0 | $0 | $9.0M |
| Operating income | -$40.0M | -$48.4M | -$78.2M | -$92.8M |
| Net income | -$39.7M | -$63.9M | -$71.1M | -$80.6M |
| EPS (diluted) | -$1.16 | -$1.87 | -$1.98 | -$2.24 |
| Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | $1.5M | $2.4M | $2.1M | $3.1M | $2.8M | $2.5M |
| Net income | -$23.4M | -$21.1M | -$12.9M | -$21.6M | -$20.2M | -$25.9M | -$22.3M | -$26.1M |
| EPS (diluted) | -$0.68 | -$0.59 | -$0.36 | -$0.60 | -$0.56 | -$0.72 | -$0.52 | -$0.58 |
| FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|
| Operating cash flow | -$36.2M | -$37.4M | -$51.5M | -$81.6M |
| Capital expenditure | -$103,000 | -$166,000 | -$366,000 | -$719,000 |
| Free cash flow | -$36.3M | -$37.5M | -$51.9M | -$82.3M |
| Dividends paid | $0 | $0 | $0 | $0 |
| Net share buybacks | $44,000 | $0 | $221.6M | $17.9M |
Cash outflows are shown as negative numbers.
- Cash and short-term investments
- $318.7M
- Total assets
- $396.9M
- Total liabilities
- $22.0M
- Total debt
- $2.8M
- Net debt
- -$71.1M
- Shareholders’ equity
- $374.9M
As of Jun 30, 2026 (filed Aug 5, 2026).
Short interest
- Shares sold short
- 3,073,976
- Days to cover
- 6.06
- Change vs previous report
- +12.9%
FINRA short interest, settlement date Sep 15, 2026.